These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 7673103

  • 21. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P, Patkar AA, Peindl K, Murray HW, Wu LT, Hubbard R.
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [Abstract] [Full Text] [Related]

  • 22. Naltrexone in alcohol dependence.
    Hartmann PM.
    Am Fam Physician; 1997 Apr; 55(5):1877-9, 1883-4. PubMed ID: 9105212
    [Abstract] [Full Text] [Related]

  • 23. Comorbid pain and opioid addiction: psychosocial and pharmacological treatments.
    Wachholtz A, Ziedonis D, Gonzalez G.
    Subst Use Misuse; 2011 Apr; 46(12):1536-52. PubMed ID: 21756033
    [Abstract] [Full Text] [Related]

  • 24. Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.
    Chen TJ, Blum K, Payte JT, Schoolfield J, Hopper D, Stanford M, Braverman ER.
    Med Hypotheses; 2004 Apr; 63(3):538-48. PubMed ID: 15288384
    [Abstract] [Full Text] [Related]

  • 25. "Narcotics helped, I thought." Recurrent traumatization and recovery from drug dependence.
    Kueppenbender K, Herman J, Khantzian E, Albanese M.
    Harv Rev Psychiatry; 2008 Apr; 16(5):308-17. PubMed ID: 18803106
    [No Abstract] [Full Text] [Related]

  • 26. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients.
    Lapham S, Forman R, Alexander M, Illeperuma A, Bohn MJ.
    J Subst Abuse Treat; 2009 Jan; 36(1):1-6. PubMed ID: 18775624
    [Abstract] [Full Text] [Related]

  • 27. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R.
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [Abstract] [Full Text] [Related]

  • 28. Integration of pharmacotherapies in the existing programs for the treatment of alcoholics: an international perspective.
    Poldrugo F.
    J Addict Dis; 1997 Jul; 16(4):65-82. PubMed ID: 9328810
    [Abstract] [Full Text] [Related]

  • 29. Combining naltrexone and behavior therapy.
    Harv Ment Health Lett; 2002 Oct; 19(4):7-8. PubMed ID: 12393329
    [No Abstract] [Full Text] [Related]

  • 30. Naltrexone treatment for alcohol dependence.
    Fuller RK, Gordis E.
    N Engl J Med; 2001 Dec 13; 345(24):1770-1. PubMed ID: 11742054
    [No Abstract] [Full Text] [Related]

  • 31. Developments in the treatment of alcoholism.
    Tinsley JA, Finlayson RE, Morse RM.
    Mayo Clin Proc; 1998 Sep 13; 73(9):857-63. PubMed ID: 9737222
    [Abstract] [Full Text] [Related]

  • 32. Naltrexone: a clinical perspective.
    Greenstein RA, Arndt IC, McLellan AT, O'Brien CP, Evans B.
    J Clin Psychiatry; 1984 Sep 13; 45(9 Pt 2):25-8. PubMed ID: 6469933
    [Abstract] [Full Text] [Related]

  • 33. Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse.
    O'Malley SS.
    Alcohol Alcohol Suppl; 1996 Mar 13; 31(1):77-81. PubMed ID: 9845042
    [Abstract] [Full Text] [Related]

  • 34. From the neurobiologic basis of alcohol dependency to pharmacologic treatment strategies: bridging the knowledge gap.
    Shea CW.
    South Med J; 2008 Feb 13; 101(2):179-85. PubMed ID: 18364621
    [Abstract] [Full Text] [Related]

  • 35. A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence.
    Roozen HG, de Waart R, van der Windt DA, van den Brink W, de Jong CA, Kerkhof AJ.
    Eur Neuropsychopharmacol; 2006 Jul 13; 16(5):311-23. PubMed ID: 16361086
    [Abstract] [Full Text] [Related]

  • 36. Naltrexone induction: psychologic and pharmacologic strategies.
    Kleber HD, Kosten TR.
    J Clin Psychiatry; 1984 Sep 13; 45(9 Pt 2):29-38. PubMed ID: 6469934
    [Abstract] [Full Text] [Related]

  • 37. A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders.
    Gastfriend DR.
    Ann N Y Acad Sci; 2014 Oct 13; 1327(1):112-30. PubMed ID: 25236185
    [Abstract] [Full Text] [Related]

  • 38. Naltrexone in the treatment of alcoholism: a clinical review.
    O'Brien CP, Volpicelli LA, Volpicelli JR.
    Alcohol; 1996 Oct 13; 13(1):35-9. PubMed ID: 8837932
    [Abstract] [Full Text] [Related]

  • 39. The effects of naltrexone on alcohol and cocaine use in dually addicted patients.
    Oslin DW, Pettinati HM, Volpicelli JR, Wolf AL, Kampman KM, O'Brien CP.
    J Subst Abuse Treat; 1999 Mar 13; 16(2):163-7. PubMed ID: 10023615
    [Abstract] [Full Text] [Related]

  • 40. Management of alcohol abuse.
    Albanese AP.
    Clin Liver Dis; 2012 Nov 13; 16(4):737-62. PubMed ID: 23101980
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.